IREN Is Down 44% in 2026. Bernstein Cut Its Target but Still Sees 158% Upside

IREN's stock rose 18.33% after reporting fiscal Q1 results, with AI cloud revenue nearly tripling. The company delayed its $4B ARR target to Jan-Feb 2027. Bernstein cut its price target to $55 but maintains an Outperform rating, citing potential 158% upside. IREN's stock is still down 43.5% in 2026, trading at $21.34.

Original reporting
Published Nov 6, 2026, 4:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 4:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IREN Is Down 44% in 2026. Bernstein Cut Its Target but Still Sees 158% Upside — source image
Decision brief

The 30-second read

$IRENNeutralMed
01

Why it matters

The earnings release provides fresh data that could drive short‑term price movement, while the target cut introduces a bearish element.

02

Market read

First‑report earnings and guidance changes for IREN create a mixed trading signal, with upside from the beat and downside from the target cut and ARR delay.

03

What to watch

Potential dilution from the $6 billion funding gap and the uncertainty around the Childress timeline could weigh on the stock.

Relevance 7/10Novelty 8/10Timing: after-hours today

Background

IREN reported a strong Q1 with AI cloud revenue up 182% and a 66% jump in total revenue, but also announced a delay in its $4 billion ARR target and a Bernstein price‑target cut due to Texas data‑center restrictions.

Company-level read

Ticker impact

$IRENNeutralHigh confidence
Context

The article discloses IREN's fiscal Q1 results, a 66% revenue rise and a target price cut to $55, providing fresh earnings data and guidance changes.

Expected impact

likely modest upside as the market prices the earnings beat, offset by pressure from the lowered price target and ARR delay

Evidence & confidence

New revenue numbers and guidance are primary disclosures; the mixed signals suggest a balanced reaction rather than a sharp move.

Market effects

Highlights growing AI cloud demand but also regulatory risk in Texas, affecting other AI‑focused miners and developers.

Texas data‑center moratorium may pressure other regional AI infrastructure providers.

Shows how political decisions can quickly affect AI‑related hardware firms worldwide.

Counterpoint

The earnings beat may be overstated if the ARR delay persists, suggesting a potential downside if Microsoft reduces its capacity orders.

Key entities

  • IREN

    AI‑focused cloud infrastructure provider listed on NASDAQ.

  • Microsoft

    Major customer for IREN's AI capacity.

Related articles

$IRENMedAI 8/10

Two big U.S.-listed Bitcoin miners plan major exit for AI

Core Scientific (CORZ) and IREN (IREN) reported Q3 results, showing significant declines in Bitcoin mining revenue and surges in AI-related income. Core Scientific's mining revenue fell to $12.3M, while colocation revenue jumped to $215.4M. IREN's mining revenue dropped to $28M, but AI cloud revenue climbed to $200M. Both companies are shifting focus to AI services.